The US Supreme Court has decided to take up a case over whether pharmaceutical companies can pay makers of generic drugs to delay release of out of patent drugs. The case centers on the maker of a hormonal treatment called Androgel by Solvay, which is owned by US drug maker Abott. Documents filed...
![]()
![]()
![]()
![]()
![]()
↧